ArticleJHLT open2026
Lung transplantation outcomes in candidates aged ≥ 70 years old: A 10-year single center experience.
Article in JHLT open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The establishment of an upper age limit for lung transplantation remains controversial. Although the International Society of Heart and Lung Transplantation designates age over 65 as high risk, contemporary evidence demonstrates septuagenarians can achieve acceptable outcomes. This study aims to elucidate the outcomes in this older demographic compared to younger patients. Methods: This is a single-center, retrospective review of all patients who received lung transplants over a 10-year period. Recipients were divided into two age groups: those under 70 and those 70 or older. The primary outcome was one-year survival, with secondary outcomes including three- and five-year survival, primary graft dysfunction, and acute kidney injury. Results: A total of 380 lung transplants were performed: 307 (81%) in patients < 70 and 73 (19%) in those ≥ 70 years old. The median age at transplant was 63 (59;67) years in the younger cohort and 72 (71;73) years in the older cohort. There were no differences between groups in gender (p = 0.08), BMI (p = 0.29), lung composite allocation subscore (p = 0.18), or lung allocation score (p = 0.08). A higher proportion of patients aged ≥ 70 years received single lung transplants (p = <0.001) and had a diagnosis of restrictive disease (p < 0.001). Postoperatively, there were no differences in length of stay (p = 0.43), primary graft dysfunction (p = 0.14), or acute kidney injury (p = 0.99) between cohorts. No differences were observed in the 1-year (0.96 [95% CI: 0.93 - 0.98] vs 0.94 [95% CI: 0.86 - 0.98]), 3-year (0.88 [95% CI: 0.83 - 0.91] vs 0.89 [95% CI: 0.79 - 0.95]), or 5-year (0.73 [95% CI: 0.66 - 0.78] vs 0.81 [95% CI: 0.67 - 0.90]) survival rates between patients under 70 and those 70 or older (Log rank: p = 0.62). Multivariable Cox regression identified higher creatinine (HR 4.56, 95% CI 1.74-11.95; p = 0.002) and pretransplant ECMO use (HR 3.85, 95% CI 1.27-11.70; p = 0.017) as independent predictors of mortality, while age ≥ 70 was not significantly associated with mortality (HR 0.67, 95% CI 0.36-1.25; p = 0.206). Conclusion: Lung transplantation in patients aged ≥70 yields short- and long-term outcomes comparable to younger recipients, supporting expanded eligibility for carefully selected older candidates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.